| Literature DB >> 32340220 |
Elena B Domènech1,2, Gemma Marfany1,2,3.
Abstract
Retinal cell survival requires an equilibrium between oxygen, reactive oxygen species, and antioxidant molecules that counteract oxidative stress damage. Oxidative stress alters cell homeostasis and elicits a protective cell response, which is most relevant in photoreceptors and retinal ganglion cells, neurons with a high metabolic rate that are continuously subject to light/oxidative stress insults. We analyze how the alteration of cellular endogenous pathways for protection against oxidative stress leads to retinal dysfunction in prevalent (age-related macular degeneration, glaucoma) as well as in rare genetic visual disorders (Retinitis pigmentosa, Leber hereditary optic neuropathy). We also highlight some of the key molecular actors and discuss potential therapies using antioxidants agents, modulators of gene expression and inducers of cytoprotective signaling pathways to treat damaging oxidative stress effects and ameliorate severe phenotypic symptoms in multifactorial and rare retinal dystrophies.Entities:
Keywords: age-related macular degeneration (AMD); glaucoma; leber hereditary optic neuropathy (LHON); oxidative stress damage; oxidative stress response; photoreceptors; retina; retinitis pigmentosa
Year: 2020 PMID: 32340220 PMCID: PMC7222416 DOI: 10.3390/antiox9040347
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1Oxidative stress agents generate Reactive Oxygen Species (ROS), which are counteracted by antioxidant enzymes. An excess of oxidative stress leads to cellular damage, which can trigger pathways for either cell survival or cell death.
Figure 2Translational start in presence or absence of cellular stress. In normal conditions and in absence of stress (green arrow pathway), eIF2B catalyzes the exchange of GDP to GTP and allows the coupling of the ternary complex to the 48S complex. The ribosomal subunit 60S can join the complex and the addition of more ribosomes to this complex make a polysome, which is able to translate the mRNA. Upon cellular stress (red arrow pathway), eIF2α is phosphorylated by stress sensor kinases and inhibits eIF2B, precluding the binding to EIF5. The ternary complex generates a 48S* complex instead, which is deficient in eIF2/eIF5 and unable to start the translation. This complex recruits TIA-1 and TIAR proteins to form the SGs. Additionally, SGs recruit more RNA binding proteins, such as PABP. mRNAs move in and out of SGs depending on the cellular translational requirements. Thus, SGs are highly dynamic complexes, in equilibrium with polysomes.
Dietary supplementation with antioxidant compounds in retinal dystrophies.
| Agent | Function | Retinal Dystrophy |
|---|---|---|
| Xanthophylls | Useful in protecting the retina from OS and ameliorating oxidative stress states | DR, AMD and RP [ |
| Zinc and Manganese | Zinc supplements exhibit antioxidant and anti-inflammatory activities, delaying oxidative processes in the long term, and manganese is a cofactor of many antioxidant agents as SODs. | DR and AMD ( |
| Alpha-lipoic acid | Essential for mitochondrial function and also induces NRF2 binding to antioxidant response elements. which is important to slow down | DR, glaucoma, AMD, RP [ |
| Curcumin | Increases the transcription of antioxidant enzymes and induces the activation of NRF2 helping to decrease oxidative stress in the retina. | Glaucoma, DR and AMD [ |
| Ubiquinone or coenzyme Q10 | Inhibits the formation of free radicals reducing the effects of oxidative stress. Moreover, it activates eNOS and mitochondrial OXPHOS decreasing blood pressure. | AMD, RP, DR and glaucoma [ |
| Omega 3 | Deficient consumption of omega-3 contributes to the degeneration of the retina. Additionally, PREDIMED (Prevention with Mediterranean Diet) is a clinical trial that followed for 6 years individuals with diabetes mellitus type 2. Patients whose diet included omega-3 polyunsaturated fatty acids, showed a 48% decreased incidence in DR. | Glaucoma, RP and DR [ |
| Spermidine | Acts as a ROS scavenger by sequestering singlet oxygen and reactive species and reduced RGC death. | Glaucoma [ |
| Lycopene | Decreases NF-κB activation and ROS production in RPE cells, while increasing Nrf2 and GSH levels. | AMD [ |
| Resveratrol | Shows antiproliferative, antiangiogenic, antioxidant, endothelial, anti-inflammatory, antiplatelet, and neurogenic activity. | Glaucoma, cataract, AMD and DR [ |
Drugs and compounds that reduce reactive oxygen species (ROS) production in retinal cells.
| Agent | Function | Retinal Dystrophy |
|---|---|---|
| Selective siRNAs (SYL040012) | Target specific β-receptors and have been demonstrated to decrease by 50% intraocular pressure 4 days after ocular administration, thus concomitantly reducing oxidative stress in RGCs. | Glaucoma [ |
| 17β-estradiol | Inhibits ROS production, preserves ATP production and mitochondrial membrane potential, and decreases cellular and mitochondrial calcium loading. Moreover, estrogen’s neuroprotective effects have been tested in RGCs in an in vivo model of glaucoma | Glaucoma [ |
| Celastrol | Intravitreal injection reduces IOP protecting RGC from death by activating the cellular antioxidant defense system, attenuating of microglial activation, inhibiting of tumor necrosis factor (TNF)-alpha, and nitric oxide synthase production. | Glaucoma [ |
| SERPINA3K | Intravitreal injection of this serine protease inhibitor demonstrated to block the expression of VEGF and TNF-α. Moreover, it suppresses ROS production and upregulate manganese superoxide dismutase and glutathione levels. | DR [ |
| PHA666859 | Blocks the p38 MAPK pathway, which plays a role in inflammatory processes. | DR [ |
| E3330 | Exhibits RPE-protective effects downregulating intracellular ROS by attenuating the levels of NF-κB as well as the secretion of monocyte chemoattractant protein-1. | AMD [ |
| BSIH | Iron favors ROS formation in the retina, for this reason, BSIH which is a protochelator is a potential therapeutic molecule. BSIH involves iron sequestration that occurs only when the cells are stressed by hydrogen peroxide. | AMD [ |
| NAC ( | Inhibits focal adhesion kinase, a kinase whose phosphorylation, induced by ROS, cause apoptosis. | DR [ |
| Ranibizumab and aflibercept | Present a therapeutic effect against acrolein-induced oxidative cytotoxicity in human ARPE-19 cells via an increase in mitochondrial bioenergetics. | AMD [ |
| AAV-SOD2 | gene therapy by overexpression of SOD2 introduced by adeno-associated viruses (AAV-SOD2) is able to attenuate oxidative stress and improve mitochondrial dysfunction of RGC and optic nerve secondary to glaucoma. | Glaucoma [ |
| Retinoids | Systemically administration reduces retinal OS and correct rod dysfunction. | DR [ |